Provider
Gabapentin ER (extended-release) [Horizant®, Gralise®] - Commercial - Effective Date 02/01/2025
Program effective Date: Feb 01, 2025
Documents & Forms Results
Displaying 361 - 370 of 3100 results
Provider
Hereditary Angioedema (HAE) - Commercial - Effective Date 02/01/2025
Program effective Date: Feb 01, 2025
Provider
Proprotein Convertase Subtilisin/kexin type 9 (PCSK9) Inhibitors - Medicaid - Effective Date 02/01/2025
Program effective Date: Feb 01, 2025
Provider
Proprotein Convertase Subtilisin/kexin type 9 (PCSK9) Inhibitors - Commercial - Effective Date 02/01/2025
Program effective Date: Feb 01, 2025
Provider
Duvyzat™ - Commercial - Effective Date 02-01-2025
Program effective Date: Feb 01, 2025
Provider
Duvyzat™ - Medicaid - Effective Date 02/01/2025
Program effective Date: Feb 01, 2025
Provider
Ohtuvayre™ - Commercial - Effective Date 02/01/2025
Program effective Date: Feb 01, 2025
Provider
Ohtuvayre™ - Medicaid - Effective Date 02/01/2025
Program effective Date: Feb 01, 2025
Provider
Topical Estrogen - Medicaid - Effective Date 02/01/2025
Program effective Date: Feb 01, 2025
Provider
Vtama® (tapinarof) - Commercial - Effective Date 02/01/2025
Program effective Date: Feb 01, 2025